SCHEMBL3574304

SCHEMBL3574304

CC(OC1CCCCC1N1CCC(=O)C1)c1cccc2ccccc12

nearest known ligand 0.58

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ KCNA5 P22460 3/20 0.58
▸ SCN5A Q14524 3/20 0.58
▸ HSD11B1 P28845 2/20 0.38
▸ METAP2 P50579 1/20 0.35
▸ METAP1 P53582 1/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ ACP3 P15309 1/20 0.34
▸ SIGMAR1 Q99720 1/20 0.34
▸ HCRTR1 O43613 1/20 0.34
▸ HCRTR2 O43614 1/20 0.34
▸ CASR P41180 1/20 0.34
▸ CYP2D6 P10635 1/20 0.33
▸ KDM2B Q8NHM5 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1762200 1.00 KCNA5 (0.58) KCNA5SCN5AHSD11B1METAP2METAP1
SCHEMBL1762342 1.00 KCNA5 (0.58) KCNA5SCN5AHSD11B1METAP2METAP1
Hydrochloric Acid SCHEMBL1762465 0.99 KCNA5 (0.57) KCNA5SCN5AHSD11B1METAP2METAP1
Hydrochloric Acid SCHEMBL1762349 0.99 KCNA5 (0.57) KCNA5SCN5AHSD11B1METAP2METAP1
Hydrochloric Acid SCHEMBL1762316 0.77 SLC18A3 (0.43) KCNA5SCN5AMETAP2METAP1MEN1
Hydrochloric Acid SCHEMBL1762428 0.77 SLC18A3 (0.43) KCNA5SCN5AMETAP2METAP1MEN1
Hydrochloric Acid SCHEMBL5949221 0.77 SLC18A3 (0.43) KCNA5SCN5AMETAP2METAP1MEN1
SCHEMBL2124869 0.76 KCNA5 (0.39) KCNA5SCN5AHSD11B1METAP2METAP1
SCHEMBL2122586 0.76 KCNA5 (0.39) KCNA5SCN5AHSD11B1METAP2METAP1
SCHEMBL2125605 0.76 KCNA5 (0.39) KCNA5SCN5AHSD11B1METAP2METAP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8188140-B2 Uses of ion channel modulating compounds CARDIOME PHARMA CORP. 2012-05-29 — — US disclosed
US-7674820-B2 Ion channel modulating activity I CARDIOME PHARMA CORP. (CA) 2010-03-09 — — US disclosed
US-20060135536-A9 Ion channel modulating activity I CARDIOME PHARMA CORP. (CA) 2006-06-22 — — US disclosed
US-20050070552-A1 Ion channel modulating activity I CARDIOME PHARMA CORP. (CA) 2005-03-31 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050070552-A1 Ion channel modulating activity I KCNN1, KCNN3, KCNH1 KCNA5 45/4885SCN5A 71/4885HSD11B1 3797/4885
US-20060135536-A9 Ion channel modulating activity I KCNN1, KCNN3, KCNH1 KCNA5 45/4885SCN5A 71/4885HSD11B1 3797/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback